Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05402878
Other study ID # People 115 Hospital
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date August 1, 2021
Est. completion date December 31, 2023

Study information

Verified date July 2022
Source 115 People's Hospital
Contact Bich Huong Nguyen
Phone +84989689525
Email bichhuong.medic@gmail.com
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Rationale: Recently, two prospective multicenter RCT reported a potential beneficial effect of endovascular thrombectomy (EVT) in patients with an acute symptomatic basilar artery occlusion (BAO). However, the high rate of crossover in BEST study and the long-term of recruitment in BASICS study influenced the validity of the results. Objective: To assess the outcomes and prognostic factors of recanalization therapy in patients with BAO, caused by a CTA/MRA/DSA confirmed occlusion of the basilar artery. Study design: This is a prospective observational study. Study population: Patients with acute ischemic stroke and a confirmed basilar artery occlusion by CTA/MRA/DSA. Main study parameters/outcomes: Favorable outcome at day 90 defined as a modified Rankin Score (mRS - functional scale) of 0-3. The estimate will be adjusted for the known prognostic variables age, time from onset to treatment, stroke severity (NIHSS), PC ASPECT and collateral flow and adjusted and unadjusted estimates with corresponding 95% confidence intervals will be reported.


Description:

Acute basilar artery thrombosis is associated with a poor prognosis. Prevalence of basilar artery occlusion are not known in Vietnam.Various treatments were tried in groups of patients with acute ischemic stroke due to basilar artery occlusion, but evidence based was not cleared previous studies. Therefore, we conduct this study to evaluate the efficacy and safety of recanalization therapies, which included intravenous thrombosis alone, endovascular alone, or bridging IVT and endovascular, in basilar artery occlusion stroke patients.


Recruitment information / eligibility

Status Recruiting
Enrollment 150
Est. completion date December 31, 2023
Est. primary completion date December 31, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Symptoms and signs compatible with ischemia in the basilar artery territory. - Basilar artery occlusion (BAO) confirmed by CTA or MRA or DSA. - Age 18 years or older - Patients were treated with one of these among therapies IVT alone, bridging IVT and thrombectomy or thrombectomy alone.. Exclusion Criteria: - Patients did not agree to enroll. Imaging exclusion criteria: - High-density lesion consistent with hemorrhage of any degree - Significant cerebellar mass effect or acute hydrocephalus

Study Design


Locations

Country Name City State
Vietnam People 115 Hospital Ho Chi Minh Ho Chi Minh City

Sponsors (1)

Lead Sponsor Collaborator
115 People's Hospital

Country where clinical trial is conducted

Vietnam, 

Outcome

Type Measure Description Time frame Safety issue
Primary favourable outcome a modified Rankin Score of 0-3 90 (± 14 days) after procedure
Secondary good outcome a modified Rankin Score of 0-2 90 (± 14 days) after procedure
Secondary mortality Number of subjects who died at 90-day follow-up/total number of subjects who participated in 90-day follow-up) x100%. 90 (± 14 days) after procedure
Secondary Dichotomized mRS score mRS (0-2 versus 3-6 and 0-4 versus 5-6 ) 90 (± 14 days) after procedure
Secondary Symptomatic intracerebral hemorrhage (sICH) SICH means any hemorrhage with neurological deterioration, as indicated by an NIHSS score that was higher by =4 points than the value at baseline or the lowest value in the first 72 hours or any hemorrhage leading to death. within 72 hours after procedure
Secondary Any intracerebral hemorrhage intracerebral hemorrhage was defined according ECASS definition. within 72 hours after procedure
Secondary Procedural related complications arterial perforation, arterial dissection, embolization in a previously uninvolved vascular territory and so on Perioperative period
See also
  Status Clinical Trial Phase
Recruiting NCT01717755 - Basilar Artery International Cooperation Study N/A
Recruiting NCT06101667 - Efficacy and Safety of Endovascular Recanalization for Acute Basilar Artery Occlusion With Extended Time Window (ANGEL-BAO) N/A
Recruiting NCT05615038 - A Comparison of Contact Aspiration Versus Stent Retriever for Acute Basilar Artery Occlusion N/A
Recruiting NCT05105633 - Extending the Time Window for Tenecteplase by Recanalization of Basilar Artery Occlusion in Posterior Circulation Stroke Phase 2/Phase 3
Recruiting NCT05320263 - Contact Aspiration Versus Stent Retriever for Recanalisation of Acute Stroke Patients With Basilar Artery Occlusion: The Posterior Circulation ASTER Randomized Trial Protocol N/A
Not yet recruiting NCT04177615 - Randomized Assessment of Rapid Endovascular Treatment in Basilar Artery Occlusion Stroke in 115 Hospital N/A
Recruiting NCT05827042 - Endovascular Thrombectomy Alone Versus Intravenous Thrombolysis Plus Thrombectomy on Acute Basilar Artery Occlusion Phase 3
Recruiting NCT05701956 - Intravenous Tenecteplase Plus EVT Versus EVT Alone on 4.5 to 24 Hours After Basilar Artery Occlusion Phase 3
Active, not recruiting NCT02737189 - Basilar Artery Occlusion Chinese Endovascular Trial N/A
Not yet recruiting NCT05580822 - Additive Effects of Intra-arterial Tenecteplase for Successful Thrombectomy Due to Acute Basilar Artery Occlusion Phase 2
Completed NCT04751708 - Endovascular Treatment for Acute Basilar Artery Occlusion N/A
Recruiting NCT05512910 - Minocycline for Acute Ischemic Stroke Undergoing Endovascular Treatment Due to Basilar Artery Occlusion (MIST-B) Phase 4
Recruiting NCT05631847 - Direct Endovascular Treatment Versus Bridging Treatment In Basilar Artery Occlusive Stroke N/A